Validation of Opsonophagocytic assay for pnemococcal vaccinekishor kulkarni
This document describes the validation of an opsonophagocytic killing assay for Streptococcus pneumoniae. The objectives of the validation study were to assess the assay's precision, linearity, accuracy, robustness, and specificity according to ICH guidelines. The results showed that the assay had 100% precision when testing multiple samples, good linearity with correlation coefficients between 0.948-1.000, 100% accuracy when compared to a reference standard, was robust to changes in effector-to-target cell ratios up to 100:1, and demonstrated specificity by inhibiting ≥80% of opsonophagocytic activity with homologous polysaccharides and ≤20% inhibition with heterologous polysaccharides. The conclusion is
India wellness industry outlook 2016 robust growth in alternativeRose088
The document provides information on a report titled "India Wellness Industry Outlook 2016 – Robust Growth in Alternative Therapy and Nutraceuticals Market". The 123-page report can be purchased for $900 in PDF format, $1200 in hard copy format, or $1650 for an enterprise license. It provides an analysis of the Indian wellness industry market size and segmentation, including categories like fitness, spa services, alternative therapies, cosmetics, and nutraceuticals. The wellness industry in India grew by 16.9% in 2011, particularly among urban residents aged 25-49. The report also covers industry trends, projections, and the market for specific segments like fitness and slimming.
India waste management and recycling market outlook to 2016Rose088
The document summarizes a report on the India Waste Management and Recycling Market Outlook from 2006-2016. The 110-page report provides an analysis of the waste industry in India, focusing on municipal solid waste, industrial hazardous waste, e-waste, and bio medical waste. It details the market size and segmentation of the waste management sector in India. Key topics covered include market sizes and projections, regulations, trends, and the competitive landscape of major players. The report analyzes factors influencing industry growth and provides future projections for waste industry segments in India.
The document discusses a report on the pipeline of treatments for Hereditary Angioedema (HAE), including 82 pages on products in development from discovery to registration, with details on companies and universities involved, 20% discounts on reports over $1000, and contact information for sample reports or questions.
The document summarizes a report on the global pipeline of treatments for congestive heart failure (CHF) in the second half of 2012. The 290-page report provides an overview of CHF and treatments currently in development, including those in late stages of testing. It profiles key companies and universities researching new CHF therapies and analyzes products at different stages of development. The report aims to help identify emerging treatments and players to inform strategic decision-making around mergers, acquisitions and competitive strategies. It is available for purchase at prices ranging from $2000 to $6000 depending on the license. Contact information is provided to request a sample or related reports on other drug pipelines.
This document summarizes a 106-page report on the pipeline of therapeutics under development for acute renal failure (ARF)/acute kidney injury. The report provides an overview of the therapeutic pipeline as of the second half of 2012, including details on late-stage, mid-clinical stage, early clinical stage, and pre-clinical products. It reviews key players and universities involved in developing treatments for ARF/acute kidney injury and allows identification of emerging companies. The report can be purchased for various license fees or a sample may be requested.
Downstream processing in biopharmaceuticals adoptionRose088
This document summarizes a report from GBI Research about downstream processing in biopharmaceuticals. It discusses the adoption of disposable technologies at larger economies of scale to optimize production efficiency and cost-effectiveness. The report provides an overview of the biopharmaceutical and contract manufacturing industries as well as the downstream processing and reagent markets. It also includes market data, forecasts, profiles of key players, and an analysis of drivers and restraints. The report aims to help readers develop market strategies and understand factors shaping the industries.
This document summarizes a market research report on the pipeline of therapies for amyloidosis. The report provides an overview of therapeutic candidates in development for amyloidosis, including their current stage of development. It analyzes pipeline products by company and university, and profiles major companies involved in developing treatments for this condition, such as GlaxoSmithKline, Isis Pharmaceuticals, and Alnylam Pharmaceuticals. Sample pages of the report can be requested by email for review.
Validation of Opsonophagocytic assay for pnemococcal vaccinekishor kulkarni
This document describes the validation of an opsonophagocytic killing assay for Streptococcus pneumoniae. The objectives of the validation study were to assess the assay's precision, linearity, accuracy, robustness, and specificity according to ICH guidelines. The results showed that the assay had 100% precision when testing multiple samples, good linearity with correlation coefficients between 0.948-1.000, 100% accuracy when compared to a reference standard, was robust to changes in effector-to-target cell ratios up to 100:1, and demonstrated specificity by inhibiting ≥80% of opsonophagocytic activity with homologous polysaccharides and ≤20% inhibition with heterologous polysaccharides. The conclusion is
India wellness industry outlook 2016 robust growth in alternativeRose088
The document provides information on a report titled "India Wellness Industry Outlook 2016 – Robust Growth in Alternative Therapy and Nutraceuticals Market". The 123-page report can be purchased for $900 in PDF format, $1200 in hard copy format, or $1650 for an enterprise license. It provides an analysis of the Indian wellness industry market size and segmentation, including categories like fitness, spa services, alternative therapies, cosmetics, and nutraceuticals. The wellness industry in India grew by 16.9% in 2011, particularly among urban residents aged 25-49. The report also covers industry trends, projections, and the market for specific segments like fitness and slimming.
India waste management and recycling market outlook to 2016Rose088
The document summarizes a report on the India Waste Management and Recycling Market Outlook from 2006-2016. The 110-page report provides an analysis of the waste industry in India, focusing on municipal solid waste, industrial hazardous waste, e-waste, and bio medical waste. It details the market size and segmentation of the waste management sector in India. Key topics covered include market sizes and projections, regulations, trends, and the competitive landscape of major players. The report analyzes factors influencing industry growth and provides future projections for waste industry segments in India.
The document discusses a report on the pipeline of treatments for Hereditary Angioedema (HAE), including 82 pages on products in development from discovery to registration, with details on companies and universities involved, 20% discounts on reports over $1000, and contact information for sample reports or questions.
The document summarizes a report on the global pipeline of treatments for congestive heart failure (CHF) in the second half of 2012. The 290-page report provides an overview of CHF and treatments currently in development, including those in late stages of testing. It profiles key companies and universities researching new CHF therapies and analyzes products at different stages of development. The report aims to help identify emerging treatments and players to inform strategic decision-making around mergers, acquisitions and competitive strategies. It is available for purchase at prices ranging from $2000 to $6000 depending on the license. Contact information is provided to request a sample or related reports on other drug pipelines.
This document summarizes a 106-page report on the pipeline of therapeutics under development for acute renal failure (ARF)/acute kidney injury. The report provides an overview of the therapeutic pipeline as of the second half of 2012, including details on late-stage, mid-clinical stage, early clinical stage, and pre-clinical products. It reviews key players and universities involved in developing treatments for ARF/acute kidney injury and allows identification of emerging companies. The report can be purchased for various license fees or a sample may be requested.
Downstream processing in biopharmaceuticals adoptionRose088
This document summarizes a report from GBI Research about downstream processing in biopharmaceuticals. It discusses the adoption of disposable technologies at larger economies of scale to optimize production efficiency and cost-effectiveness. The report provides an overview of the biopharmaceutical and contract manufacturing industries as well as the downstream processing and reagent markets. It also includes market data, forecasts, profiles of key players, and an analysis of drivers and restraints. The report aims to help readers develop market strategies and understand factors shaping the industries.
This document summarizes a market research report on the pipeline of therapies for amyloidosis. The report provides an overview of therapeutic candidates in development for amyloidosis, including their current stage of development. It analyzes pipeline products by company and university, and profiles major companies involved in developing treatments for this condition, such as GlaxoSmithKline, Isis Pharmaceuticals, and Alnylam Pharmaceuticals. Sample pages of the report can be requested by email for review.
This document summarizes a market research report from Global Markets Direct about Incyte Corporation's product pipeline as of 2012. It provides an overview of Incyte's research areas and pipeline of drug candidates, including those in late-stage development and clinical trials. Key information is given about Incyte's business and locations. The full report contains additional details on pipeline candidates like mechanisms of action, development progress updates, and discontinued projects. It also includes tables, figures and references to related reports available from the publisher.
The document summarizes a market research report on the Chinese markets for industrial lubricants. It examines China's economic trends, industry development, supply and demand for industrial lubricants in China. The report provides historical data from 2001 to 2011 and forecasts through 2016 and 2021. It profiles major lubricant producers in China and analyzes the industrial lubricants industry capacity, market share, technology development and major end-users. The full report is available for 50% off at $2000 and contains sections on business environment, industry assessments, and production and demand for various industrial lubricants.
This document summarizes a book about national security in Mumbai. It includes 18 chapters covering various sectors like transport, power, telecom, and others. It discusses security requirements and challenges for each sector. The book aims to assess the implications of security technologies and develop an effective system to address emerging threats. It also includes security requirements for Indian states, union territories, and some other countries.
This document summarizes a market research report on the product pipeline of Zydus Cadila Healthcare Limited. The report provides details on Zydus Cadila's research areas and developmental pipeline, including current projects in various stages of development across different therapy areas. It also lists several of Zydus Cadila's pipeline candidates, including their descriptions and development progress. Contact information is provided for requesting a sample of the full market research report.
Ziopharm oncology, inc. – product pipeline review – 2012Rose088
The document summarizes a market research report on ZIOPHARM Oncology, Inc.'s product pipeline as of 2012. It provides an overview of ZIOPHARM's research areas and developmental pipeline, including projects in various stages of development across different therapy areas. The report also includes snapshots of key pipeline candidates such as Ad-IL-12 and DC-IL-12, along with their descriptions, mechanisms of action, and research progress. Tables of contents and figures from the full report are listed as well.
Topo target a s – product pipeline review – 2012Rose088
The document summarizes a market research report from Global Markets Direct about the product pipeline of TopoTarget A/S, a pharmaceutical company. The report provides details on TopoTarget's current developmental pipeline, including projects in clinical trials and pre-clinical research across various therapy areas. It also profiles several of TopoTarget's key pipeline drugs and combination treatment modalities in development, including their descriptions, mechanisms of action, and research progress. Contact information is provided to request a sample of the full report or for questions.
Macro genics, inc. – product pipeline review – 2012Rose088
This document summarizes a market research report about MacroGenics, Inc.'s product pipeline as of 2012. It provides an overview of MacroGenics' research areas, pipeline of products in development across various therapy areas and stages of the drug development process. It also includes brief profiles of some of MacroGenics' key pipeline products in development, such as DART for autoimmune disorders, DART mAbs, and monoclonal antibodies. The full report contains additional details on MacroGenics' pipeline like lists of tables and figures as well as related reports that can be purchased.
Ym bio sciences inc. – product pipeline review – 2012Rose088
This document summarizes a market research report on YM BioSciences Inc.'s product pipeline as of 2012. It provides an overview of YM BioSciences' business and focus on key therapeutic areas. The report also details YM's pipeline of candidates in various stages of clinical development, including Phase III, Phase II and Phase I trials, as well as combination treatment modalities. It profiles several of YM's lead pipeline candidates and outlines their mechanisms of action and development progress. Contact information is provided to request a sample of the full report or for additional related pharmaceutical reports.
The document announces the availability of a market research report on the Astrocytoma therapeutic pipeline from Global Markets Direct. The report provides an overview and details on drug candidates in development for Astrocytoma, including those from companies and universities. It covers products from discovery to registration stages and key players involved. Sample pages of the report can be requested by email.
Ipsen inc. – product pipeline review – 2012Rose088
This document summarizes a market research report on Ipsen Inc.'s product pipeline in 2012. The report provides an overview of Ipsen's research areas and pipeline of drugs in development, including those in Phase III clinical trials. It also lists Ipsen's locations and subsidiaries. The document encourages requesting a sample of the full market research report or searching for similar reports on pharmaceutical pipelines and healthcare topics through the Aarkstore website.
This document summarizes a market research report on MethylGene Inc's product pipeline as of 2012. The report provides details on MethylGene's research areas and pipeline of drug candidates at various stages of clinical trials. It describes several of MethylGene's lead drug candidates, including their mechanisms of action and development progress. Tables of contents and figures are included listing the report's contents. Contact information is provided to request a sample or purchase the full report.
This document summarizes a market research report on MerLion Pharmaceuticals Pte Ltd's product pipeline as of 2012. The report provides an overview of MerLion's research areas and developmental pipeline, including both current and discontinued/dormant projects. It describes the various stages of drug development for molecules across MerLion's portfolio in therapeutic areas such as anti-virulence, antibiotics, and anti-fungals. Tables and figures in the report provide additional details on MerLion's clinical and early-stage pipeline products. Contact information is provided for inquiries about purchasing the full report.
This document summarizes a market research report on Glenmark Pharmaceuticals Ltd's product pipeline as of 2012. The report provides details on Glenmark's research areas and pipeline of drug candidates at various stages of development, including 4 drugs in late-stage Phase III trials and several others in early-stage pre-clinical testing. Tables of contents and figures are included listing the pipeline drugs and studies. Contact information is provided to request a sample or related reports on pharmaceutical company pipelines and products.
This document summarizes a market research report from Global Markets Direct about Geron Corporation's product pipeline as of 2012. The report provides an overview of Geron's research areas and pipeline of drug candidates, including those in clinical trials for cancer and other conditions. It describes five of Geron's lead candidates in development - GRN1005, GRN163L, a combination of GRN163L with paclitaxel and bevacizumab, a combination of GRN163L with paclitaxel and carboplatin, and GRN510. Details provided on each candidate include its description, mechanism of action, and development progress.
Immuno gen, inc. – product pipeline review – 2012Rose088
The document summarizes a market research report on ImmunoGen, Inc.'s product pipeline as of 2012. It provides an overview of ImmunoGen's research areas and developmental pipeline, including current projects in various stages of development for cancer treatments. The report is compiled using data from ImmunoGen's corporate resources as well as third party sources, and includes profiles for several of ImmunoGen's lead pipeline candidates with details on their descriptions, mechanisms of action, and research progress. Links are also provided to other related product pipeline reports available.
7 tm pharma as – product pipeline review – 2012Rose088
The document summarizes a market research report on the product pipeline of 7TM Pharma A/S, a pharmaceutical company. It provides details on 7TM Pharma's current pipeline, including developmental stages of pipeline products across various therapy areas. Key pipeline molecules discussed include a drug for metabolic disorders, PAD program, TM30339, TM30510, and TM38837. The report also analyzes 7TM Pharma's research and development focus and pipeline.
The document announces the availability of a new market research report from GBI Research titled "Emerging Power Markets in South-East Asia, Middle East and Africa to 2020 - Government’s Restructuring Reforms Encouraging Private Participation will Enhance Price Competition and Efficiency". The report provides an analysis of the power markets, regulatory frameworks, and forecasts for installed capacity and generation in 7 countries in those regions through 2020. It also includes details on consumption, tables of contents, and links to other related reports.
The document summarizes a market research report from GBI Research about how cloud computing can optimize data management in pharmaceutical research and development, particularly for next-generation DNA sequencing and clinical trials data; it provides an overview of cloud computing technologies and models as well as applications in the pharmaceutical industry and competitive landscape of major cloud computing providers.
This document announces the availability of a market research report on Shire Plc's product pipeline as of 2012. The report provides an overview of Shire's research areas and pipeline of drugs in development, including those in late stage registration and clinical trials. It includes profiles for several of Shire's pipeline drugs in development, describing their purpose, mechanisms of action, and research progress. Contact information is provided to request a sample or purchase the full report.
Mundipharma international limited – product pipeline review – 2012Rose088
The document announces the availability of a market research report on Mundipharma International Limited's product pipeline as of 2012. The report provides an overview of Mundipharma's research and development focus areas and current developmental pipeline, including projects in various stages of development across therapeutic areas. It includes a snapshot of Mundipharma, descriptions of pipeline products like Bendamustine Hydrochloride and Flutiform, and contact information for requesting a sample of the full report.
Milan J. Anadkat, MD, and Dale V. Reisner discuss generalized pustular psoriasis in this CME activity titled "Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communications Strategies to Improve Shared Decision-Making." For the full presentation, please visit us at www.peervoice.com/HUM870.
Nutritional deficiency Disorder are problems in india.
It is very important to learn about Indian child's nutritional parameters as well the Disease related to alteration in their Nutrition.
This document summarizes a market research report from Global Markets Direct about Incyte Corporation's product pipeline as of 2012. It provides an overview of Incyte's research areas and pipeline of drug candidates, including those in late-stage development and clinical trials. Key information is given about Incyte's business and locations. The full report contains additional details on pipeline candidates like mechanisms of action, development progress updates, and discontinued projects. It also includes tables, figures and references to related reports available from the publisher.
The document summarizes a market research report on the Chinese markets for industrial lubricants. It examines China's economic trends, industry development, supply and demand for industrial lubricants in China. The report provides historical data from 2001 to 2011 and forecasts through 2016 and 2021. It profiles major lubricant producers in China and analyzes the industrial lubricants industry capacity, market share, technology development and major end-users. The full report is available for 50% off at $2000 and contains sections on business environment, industry assessments, and production and demand for various industrial lubricants.
This document summarizes a book about national security in Mumbai. It includes 18 chapters covering various sectors like transport, power, telecom, and others. It discusses security requirements and challenges for each sector. The book aims to assess the implications of security technologies and develop an effective system to address emerging threats. It also includes security requirements for Indian states, union territories, and some other countries.
This document summarizes a market research report on the product pipeline of Zydus Cadila Healthcare Limited. The report provides details on Zydus Cadila's research areas and developmental pipeline, including current projects in various stages of development across different therapy areas. It also lists several of Zydus Cadila's pipeline candidates, including their descriptions and development progress. Contact information is provided for requesting a sample of the full market research report.
Ziopharm oncology, inc. – product pipeline review – 2012Rose088
The document summarizes a market research report on ZIOPHARM Oncology, Inc.'s product pipeline as of 2012. It provides an overview of ZIOPHARM's research areas and developmental pipeline, including projects in various stages of development across different therapy areas. The report also includes snapshots of key pipeline candidates such as Ad-IL-12 and DC-IL-12, along with their descriptions, mechanisms of action, and research progress. Tables of contents and figures from the full report are listed as well.
Topo target a s – product pipeline review – 2012Rose088
The document summarizes a market research report from Global Markets Direct about the product pipeline of TopoTarget A/S, a pharmaceutical company. The report provides details on TopoTarget's current developmental pipeline, including projects in clinical trials and pre-clinical research across various therapy areas. It also profiles several of TopoTarget's key pipeline drugs and combination treatment modalities in development, including their descriptions, mechanisms of action, and research progress. Contact information is provided to request a sample of the full report or for questions.
Macro genics, inc. – product pipeline review – 2012Rose088
This document summarizes a market research report about MacroGenics, Inc.'s product pipeline as of 2012. It provides an overview of MacroGenics' research areas, pipeline of products in development across various therapy areas and stages of the drug development process. It also includes brief profiles of some of MacroGenics' key pipeline products in development, such as DART for autoimmune disorders, DART mAbs, and monoclonal antibodies. The full report contains additional details on MacroGenics' pipeline like lists of tables and figures as well as related reports that can be purchased.
Ym bio sciences inc. – product pipeline review – 2012Rose088
This document summarizes a market research report on YM BioSciences Inc.'s product pipeline as of 2012. It provides an overview of YM BioSciences' business and focus on key therapeutic areas. The report also details YM's pipeline of candidates in various stages of clinical development, including Phase III, Phase II and Phase I trials, as well as combination treatment modalities. It profiles several of YM's lead pipeline candidates and outlines their mechanisms of action and development progress. Contact information is provided to request a sample of the full report or for additional related pharmaceutical reports.
The document announces the availability of a market research report on the Astrocytoma therapeutic pipeline from Global Markets Direct. The report provides an overview and details on drug candidates in development for Astrocytoma, including those from companies and universities. It covers products from discovery to registration stages and key players involved. Sample pages of the report can be requested by email.
Ipsen inc. – product pipeline review – 2012Rose088
This document summarizes a market research report on Ipsen Inc.'s product pipeline in 2012. The report provides an overview of Ipsen's research areas and pipeline of drugs in development, including those in Phase III clinical trials. It also lists Ipsen's locations and subsidiaries. The document encourages requesting a sample of the full market research report or searching for similar reports on pharmaceutical pipelines and healthcare topics through the Aarkstore website.
This document summarizes a market research report on MethylGene Inc's product pipeline as of 2012. The report provides details on MethylGene's research areas and pipeline of drug candidates at various stages of clinical trials. It describes several of MethylGene's lead drug candidates, including their mechanisms of action and development progress. Tables of contents and figures are included listing the report's contents. Contact information is provided to request a sample or purchase the full report.
This document summarizes a market research report on MerLion Pharmaceuticals Pte Ltd's product pipeline as of 2012. The report provides an overview of MerLion's research areas and developmental pipeline, including both current and discontinued/dormant projects. It describes the various stages of drug development for molecules across MerLion's portfolio in therapeutic areas such as anti-virulence, antibiotics, and anti-fungals. Tables and figures in the report provide additional details on MerLion's clinical and early-stage pipeline products. Contact information is provided for inquiries about purchasing the full report.
This document summarizes a market research report on Glenmark Pharmaceuticals Ltd's product pipeline as of 2012. The report provides details on Glenmark's research areas and pipeline of drug candidates at various stages of development, including 4 drugs in late-stage Phase III trials and several others in early-stage pre-clinical testing. Tables of contents and figures are included listing the pipeline drugs and studies. Contact information is provided to request a sample or related reports on pharmaceutical company pipelines and products.
This document summarizes a market research report from Global Markets Direct about Geron Corporation's product pipeline as of 2012. The report provides an overview of Geron's research areas and pipeline of drug candidates, including those in clinical trials for cancer and other conditions. It describes five of Geron's lead candidates in development - GRN1005, GRN163L, a combination of GRN163L with paclitaxel and bevacizumab, a combination of GRN163L with paclitaxel and carboplatin, and GRN510. Details provided on each candidate include its description, mechanism of action, and development progress.
Immuno gen, inc. – product pipeline review – 2012Rose088
The document summarizes a market research report on ImmunoGen, Inc.'s product pipeline as of 2012. It provides an overview of ImmunoGen's research areas and developmental pipeline, including current projects in various stages of development for cancer treatments. The report is compiled using data from ImmunoGen's corporate resources as well as third party sources, and includes profiles for several of ImmunoGen's lead pipeline candidates with details on their descriptions, mechanisms of action, and research progress. Links are also provided to other related product pipeline reports available.
7 tm pharma as – product pipeline review – 2012Rose088
The document summarizes a market research report on the product pipeline of 7TM Pharma A/S, a pharmaceutical company. It provides details on 7TM Pharma's current pipeline, including developmental stages of pipeline products across various therapy areas. Key pipeline molecules discussed include a drug for metabolic disorders, PAD program, TM30339, TM30510, and TM38837. The report also analyzes 7TM Pharma's research and development focus and pipeline.
The document announces the availability of a new market research report from GBI Research titled "Emerging Power Markets in South-East Asia, Middle East and Africa to 2020 - Government’s Restructuring Reforms Encouraging Private Participation will Enhance Price Competition and Efficiency". The report provides an analysis of the power markets, regulatory frameworks, and forecasts for installed capacity and generation in 7 countries in those regions through 2020. It also includes details on consumption, tables of contents, and links to other related reports.
The document summarizes a market research report from GBI Research about how cloud computing can optimize data management in pharmaceutical research and development, particularly for next-generation DNA sequencing and clinical trials data; it provides an overview of cloud computing technologies and models as well as applications in the pharmaceutical industry and competitive landscape of major cloud computing providers.
This document announces the availability of a market research report on Shire Plc's product pipeline as of 2012. The report provides an overview of Shire's research areas and pipeline of drugs in development, including those in late stage registration and clinical trials. It includes profiles for several of Shire's pipeline drugs in development, describing their purpose, mechanisms of action, and research progress. Contact information is provided to request a sample or purchase the full report.
Mundipharma international limited – product pipeline review – 2012Rose088
The document announces the availability of a market research report on Mundipharma International Limited's product pipeline as of 2012. The report provides an overview of Mundipharma's research and development focus areas and current developmental pipeline, including projects in various stages of development across therapeutic areas. It includes a snapshot of Mundipharma, descriptions of pipeline products like Bendamustine Hydrochloride and Flutiform, and contact information for requesting a sample of the full report.
Milan J. Anadkat, MD, and Dale V. Reisner discuss generalized pustular psoriasis in this CME activity titled "Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communications Strategies to Improve Shared Decision-Making." For the full presentation, please visit us at www.peervoice.com/HUM870.
Nutritional deficiency Disorder are problems in india.
It is very important to learn about Indian child's nutritional parameters as well the Disease related to alteration in their Nutrition.
- Video recording of this lecture in English language: https://youtu.be/RvdYsTzgQq8
- Video recording of this lecture in Arabic language: https://youtu.be/ECILGWtgZko
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
CLASSIFICATION OF H1 ANTIHISTAMINICS-
FIRST GENERATION ANTIHISTAMINICS-
1)HIGHLY SEDATIVE-DIPHENHYDRAMINE,DIMENHYDRINATE,PROMETHAZINE,HYDROXYZINE 2)MODERATELY SEDATIVE- PHENARIMINE,CYPROHEPTADINE, MECLIZINE,CINNARIZINE
3)MILD SEDATIVE-CHLORPHENIRAMINE,DEXCHLORPHENIRAMINE
TRIPROLIDINE,CLEMASTINE
SECOND GENERATION ANTIHISTAMINICS-FEXOFENADINE,
LORATADINE,DESLORATADINE,CETIRIZINE,LEVOCETIRIZINE,
AZELASTINE,MIZOLASTINE,EBASTINE,RUPATADINE. Mechanism of action of 2nd generation antihistaminics-
These drugs competitively antagonize actions of
histamine at the H1 receptors.
Pharmacological actions-
Antagonism of histamine-The H1 antagonists effectively block histamine induced bronchoconstriction, contraction of intestinal and other smooth muscle and triple response especially wheal, flare and itch. Constriction of larger blood vessel by histamine is also antagonized.
2) Antiallergic actions-Many manifestations of immediate hypersensitivity (type I reactions)are suppressed. Urticaria, itching and angioedema are well controlled.3) CNS action-The older antihistamines produce variable degree of CNS depression.But in case of 2nd gen antihistaminics there is less CNS depressant property as these cross BBB to significantly lesser extent.
4) Anticholinergic action- many H1 blockers
in addition antagonize muscarinic actions of ACh. BUT IN 2ND gen histaminics there is Higher H1 selectivitiy : no anticholinergic side effects
Selective alpha1 blockers are Prazosin, Terazosin, Doxazosin, Tamsulosin and Silodosin majorly used to treat BPH, also hypertension, PTSD, Raynaud's phenomenon, CHF
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
Congestive Heart failure is caused by low cardiac output and high sympathetic discharge. Diuretics reduce preload, ACE inhibitors lower afterload, beta blockers reduce sympathetic activity, and digitalis has inotropic effects. Newer medications target vasodilation and myosin activation to improve heart efficiency while lowering energy requirements. Combination therapy, following an assessment of cardiac function and volume status, is the most effective strategy to heart failure care.
Fexofenadine is sold under the brand name Allegra.
It is a selective peripheral H1 blocker. It is classified as a second-generation antihistamine because it is less able to pass the blood–brain barrier and causes lesser sedation, as compared to first-generation antihistamines.
It is on the World Health Organization's List of Essential Medicines. Fexofenadine has been manufactured in generic form since 2011.
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
3. Summary
Global Markets Direct’s, Streptococcus Pneumoniae (Pneumococcus) Infections -
Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic
pipeline. This report provides information on the therapeutic development for
Streptococcus Pneumoniae (Pneumococcus) Infections, complete with latest
updates, and special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for Streptococcus
Pneumoniae (Pneumococcus) Infections. Streptococcus Pneumoniae
(Pneumococcus) Infections - Pipeline Review, Half Year is built using data and
information sourced from Global Markets Direct’s proprietary
databases, Company/University websites, SEC filings, investor presentations
and featured press releases from company/university sites and industry-
specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
4. Scope
- A snapshot of the global therapeutic scenario for Streptococcus Pneumoniae
(Pneumococcus) Infections.
- A review of the Streptococcus Pneumoniae (Pneumococcus) Infections products
under development by companies and universities/research institutes based on
information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Streptococcus Pneumoniae (Pneumococcus) Infections.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.
5. Table of Contents :
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Streptococcus Pneumoniae (Pneumococcus) Infections Overview 9
Therapeutics Development 10
An Overview of Pipeline Products for Streptococcus Pneumoniae
(Pneumococcus) Infections 10
Streptococcus Pneumoniae (Pneumococcus) Infections Therapeutics under
Development by Companies 12
Streptococcus Pneumoniae (Pneumococcus) Infections Therapeutics under
Investigation by Universities/Institutes 15
Late Stage Products 16
Comparative Analysis 16
Mid Clinical Stage Products 17
Comparative Analysis 17
Early Clinical Stage Products 18
Comparative Analysis 18
Discovery and Pre-Clinical Stage Products 19
Comparative Analysis 19………….
6. Please follow link if you want More Related
Reports :
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?searc
h=Pipeline Review, H2 2012&PubId=&pagenum=1